Results 1 to 10 of about 165 (97)
Statin-Induced Autoimmune Necrotizing Myopathy [PDF]
Statin therapy is a widely prescribed medication class for hypercholesterolemia. In statin-induced autoimmune myopathy, genetically predisposed and at-risk patients can develop antibodies against hydroxy-3-methylglutaryl-CoA reductase (HMGCR), the key ...
exaly +4 more sources
Statin-Induced Necrotizing Autoimmune Myopathy
Statin-induced necrotizing autoimmune myopathy (SINAM) is an exceptionally rare yet devastating complication of statin therapy that can occur at any time after initiation.
Manasi Tannu, Laurence Sperling
exaly +8 more sources
Statin‐associated necrotizing autoimmune myopathy with concurrent myasthenia gravis [PDF]
Statin treatment has been associated with necrotizing autoimmune myopathy and has been linked to myasthenia gravis. We present an unprecedented clinical challenge with both disorders occurring in a patient treated with statins few months earlier.
Emma Frasson +2 more
exaly +6 more sources
Necrotizing autoimmune myopathy
Necrotizing autoimmune myopathy (NAM) is categorized as one of the idiopathic immune-mediated myopathies. It is characterized by subacute predominantly proximal weakness, elevated serum creatine kinase, and a muscle biopsy showing predominantly necrotic and regenerating fibers with absent or minimal inflammation.
Sachin Suresh Babu +5 more
doaj +6 more sources
Necrotizing Autoimmune Myopathy: A Rare Variant of Idiopathic Inflammatory Myopathies [PDF]
Idiopathic inflammatory myopathies are an unusual group of myopathies with annual incidence of 1 in 100 000 people in the United States. Necrotizing autoimmune myopathy comprises only 16% of this group.
Noman Ahmed Jang Khan MD +4 more
doaj +3 more sources
Statin-induced necrotizing autoimmune myopathy: a systematic review
Statins are a class of lipid-lowering medications used worldwide by millions of people and are safe for frequent use in most patients. However, they cause necrotizing autoimmune myopathy in some patients. We reviewed case reports of 80 patients from 2010
Manoj Reddy Somagutta +9 more
doaj +3 more sources
Although 3-hydroxy-3-methyl-glutaryl-coenzyme A (HMG-CoA) reductase inhibitors are well tolerated, a small subset of patients may develop autoimmune myopathy, classified as immune-mediated necrotizing myopathy.
Marina Roytman, Hunza Chaudhry
exaly +2 more sources
Seronegative necrotizing autoimmune myopathy with favorable response to intravenous immunoglobulin
We describe a 68-year-old man who presented with progressive weakness in proximal muscles of all four limbs and was found to have autoantibody-negative necrotizing autoimmune myopathy (NAM). His myopathy was refractory to corticosteroids and methotrexate, but subsequently demonstrated successful response to intravenous immunoglobulin (IVIG).
Rebecca Liu, Andrew Fenves
exaly +4 more sources
An Unusual Case of Statin-Induced Myopathy: Anti-HMGCoA Necrotizing Autoimmune Myopathy [PDF]
Statins are some of the most widely prescribed medications, and though generally well tolerated, can lead to a self-limited myopathy in a minority of patients. Recently, these medications have been associated with a necrotizing autoimmune myopathy (NAM).
Chamindra G Laverty +2 more
exaly +3 more sources
Statin-induced necrotizing autoimmune myopathy: an extremely rare adverse effect from statin use
Statins are widely prescribed medications to prevent cardiovascular events. While self-limited statin myopathy is relatively common, statin-induced necrotizing autoimmune myopathy (SINAM) is extremely uncommon, with incidence of two cases per million per
Rashmi Dhital +2 more
exaly +2 more sources

